News & Perspective

Jan 23, 2013

Jan 23, 2013

Research moratorium on modified H5N1 viruses ends

(CIDRAP News) – A year-long voluntary moratorium on research involving transmissible H5N1 avian flu viruses ended today with a letter from a group of scientists that supports resuming the work in countries that have addressed the biosafety issues involved.

Feb 21, 2013

Feb 21, 2013

Feds unveil new policies for 'dual-use' H5N1 research

(CIDRAP News) – Federal officials announced two new policy steps today designed to guide how they and US labs address dual-use research on dangerous pathogens, especially experiments involving aerosol H5N1 avian flu transmission.

Apr 03, 2013

Apr 03, 2013

NBSB unveils situational awareness, SNS recommendations

(CIDRAP News) – The National Biodefense Science Board (NBSB) today forwarded two sets of recommendations to federal departments that oversee emergency preparedness, one focused on enhancing situational awareness in health emergencies and the other on improving the nation's Strategic National Stockpile (SNS) by 2020.

May 01, 2013

May 01, 2013

WHO report: Global guidance on dual-use research needed

(CIDRAP News) – Participants in a World Health Organization (WHO) meeting held in February agreed that a binding global agreement to govern potentially dangerous life-sciences research is unlikely, but global guidance on the thorny issue could help nations figure out their own policies, according to a WHO report of the meeting.

May 02, 2013

May 02, 2013

Study: Lab-made H5N1-H1N1 viruses spread in guinea pigs

(CIDRAP News) – Chinese scientists report that lab-generated hybrid viruses combining genes from avian H5N1 and pandemic 2009 H1N1 (pH1N1) influenza viruses can achieve airborne spread between guinea pigs, a finding that seems likely to renew the debate about the risks of creating novel viruses that might be able to spark a human pandemic.

Aug 14, 2013

Aug 14, 2013
H5N1 color electron micro

Study: Technique adds 'kill switch' to modified flu viruses

A new molecular strategy could diffuse some of the controversy over lab-modified flu viruses.

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»